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We have previously identified multipotent neuroepithelial (NEP) stem cells and lineage-restricted, self-renewing precursor
cells termed NRPs (neuron-restricted precursors) and GRPs (glial-restricted precursors) present in the developing rat spinal
cord (A. Kalyani, K. Hobson, and M. S. Rao, 1997, Dev. Biol. 186, 202–223; M. S. Rao and M. Mayer-Proschel, 1997, Dev.
iol. 188, 48–63; M. Mayer-Proschel, A. J. Kalyani, T. Mujtaba, and M. S. Rao, 1997, Neuron 19, 773–785). We now show
hat cells identical to rat NEPs, NRPs, and GRPs are present in mouse neural tubes and that immunoselection against cell
urface markers E-NCAM and A2B5 can be used to isolate NRPs and GRPs, respectively. Restricted precursors similar to
RPs and GRPs can also be isolated from mouse embryonic stem cells (ES cells). ES cell-derived NRPs are E-NCAM
mmunoreactive, undergo self-renewal in defined medium, and differentiate into multiple neuronal phenotypes in mass
ulture. ES cells also generate A2B5-immunoreactive cells that are similar to E9 NEP-cell-derived GRPs and can
ifferentiate into oligodendrocytes and astrocytes. Thus, lineage restricted precursors can be generated in vitro from
ultured ES cells and these restricted precursors resemble those derived from mouse neural tubes. These results demonstrate
he utility of using ES cells as a source of late embryonic precursor cells. © 1999 Academic Press
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HINTRODUCTION
Pluripotent stem cells in the central nervous system
(CNS) generate differentiated neurons and glia either di-
rectly or through the generation of lineage restricted inter-
mediate precursors (Kalyani and Rao, 1999; Kilpatrick and
Bartlett, 1993, 1995; Price et al., 1988, 1992; Reynolds et al.,
1992; Reynolds and Weiss, 1996; Temple and Davis, 1994;
Williams, 1995). We have shown multipotent neuroepithe-
lial (NEP) cells to be present in the spinal cord of E10.5 rats.
NEP cells are self-renewing cells that can differentiate into
neurons, oligodendrocytes, astrocytes (Kalyani et al., 1997),
and peripheral nervous system (PNS) derivatives (Mujtaba
et al., 1998). Differentiation of NEP cells occurs via the
generation of more restricted precursors. At E13.5, two
major types of lineage restricted precursors are present: an
1 To whom correspondence should be addressed. E-mail:rao@
smsscc.med.utah.edu.
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All rights of reproduction in any form reserved.-NCAM-immunoreactive neuronal-restricted precursor
ermed an NRP, that can generate multiple kinds of neu-
ons but not oligodendrocytes or astrocytes (Mayer-
roschel et al., 1997; Kalyani et al., 1998), and an A2B5-
mmunoreactive glial-restricted precursor termed a
lial-restricted precursors (GRP) that can generate oligoden-
rocytes and astrocytes, but cannot generate neurons (Rao
nd Mayer-Proschel, 1997; Mayer-Proschel et al., 1997; Rao
t al., 1998). The multipotent NEP cell present at E10.5 is
ineally related to the neuron-restricted precursors (NRPs)
nd GRPs and a transition from NEP cells to intermediate
estricted precursors has been documented in both mass
nd clonal cultures (Mayer-Proschel et al., 1997; Rao and
ayer-Proschel, 1997; Rao et al., 1998).
Cells similar to NEPs, NRPs, and GRPs have not yet been
escribed in mouse or chick embryos. Multipotent stem
ells exist both in the mouse cortex (Reynolds et al., 1992;
ulspas et al., 1997; reviewed in McKay, 1997) and in thepinal cord (Kilpatrick and Bartlett, 1993, 1995; Weiss et al.,
113
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114 Mujtaba et al.1996a,b) but these differ significantly from rat NEP cells in
growth factor requirements, culture conditions, and differ-
entiation potential (reviewed in Kalyani and Rao, 1999). It
remains to be determined whether NEP-like stem cells
exist in the developing mouse spinal cord. Like NEP cells,
GRP-like cells have not been isolated from either the
developing mouse cortex or the mouse embryonic neural
tube although O-2A-like glial progenitors have been iden-
tified in the optic nerve and cortex at late embryonic ages
(reviewed in Collarini et al., 1991). Likewise, NRPs have
not been described in the mouse spinal cord although
neuronally restricted precursor cells have been described in
the subventricular zone and hippocampus by clonal analy-
sis in vivo and in vitro (Young and Levison,1996; Luskin et
l., 1988; Williams and Price, 1995; Williams, 1995). In
hick embryos, the existence of spinal cord NRPs has been
emonstrated by retroviral tracing (Leber et al., 1990; Leber
nd Sanes, 1995) suggesting that such cells exist during
ormal development. In addition, NRP cell lines that are
-NCAM immunoreactive and phenotypically similar to
at NRPs have been generated from human spinal cord
ultures (Li et al., 1998), further suggesting that such
ineage-restricted precursors are not unique to the rat spinal
ord and that precursors similar to NRPs and GRPs may
xist in mouse tissue as well.
Although lineage-restricted precursors may exist in the
ouse spinal cord, their antigenic characteristics, growth
rofile, and growth factor response may be different. For
xample, antibodies against A2B5 in rat cultures appear to
abel glial precursors (Rao and Mayer-Proschel, 1997), while
n mice, A2B5 recognizes an epitope also expressed by
euronal precursors (Eisenbarth et al., 1979v; our unpub-
ished results). Culture conditions and proliferative poten-
ial may also differ. For example, human cortical stem cells
re more difficult to maintain in culture than mouse
recursor cells (Svendsen et al., 1996). The fibroblast
rowth factor (FGF) sensitivity of rat and mouse cells may
lso be different (Rao and Anderson, 1997). Thus, charac-
erizing the proliferative potential, phenotypic markers,
nd differentiation properties will be critical for future
nalyses of mouse precursor cell cultures.
A specific incentive for describing growth and differen-
iation potential of restricted neural precursors in mice is
he ability to analyze the effects of single gene defects in
ultures of cells from transgenic and gene knockout mice.
imilar analysis remains difficult in most other organisms
s embryonic stem (ES) cell lines which represent the
arliest totipotent cell have until recently been generated
nly from mice (reviewed in Thompson and Marshall,
998). ES cells have been shown to recapitulate normal
ifferentiation in vitro (Fraichard et al., 1995; Okabe et al.,
996; Li et al., 1998). Postmitotic neurons and glia gener-
ted from ES cells appear phenotypically normal and inte-
rate and function normally after transplantation (Thomp-
on et al., 1998). For example, McKay and colleagues
howed that ES-cell-derived neural stem cells could be
aintained in culture and that these nestin-
Copyright © 1999 by Academic Press. All rightmmunoreactive cells could subsequently be induced to
enerate multiple classes of neurons (Okabe et al., 1996).
qually importantly, the sequential development of pluri-
otent cells into specialized CNS derivatives appears to
nvolve many of the same cytokines and transcription
actors identified as being important in normal develop-
ent (Gajovic et al., 1997; Nye et al., 1994). These obser-
ations raise the possibility that it may be possible to
solate NRPs and GRPs from ES cells maintained in culture,
ather than from developing embryos. To utilize such a
ystem, however, it is necessary to identify neural- and
lial-restricted precursors in mice similar to those we have
reviously characterized from the developing rat spinal
ord. These experiments have not been attempted previ-
usly, because well-characterized cell surface markers that
istinguish neuroblasts and glioblasts from other differen-
iating cells were unavailable.
Our recent results have identified highly polysialated
CAM (E-NCAM) and A2B5 as cell surface markers that
ay be used to select neuroblasts and glioblasts, respec-
ively. In this study, we have used both markers to show
hat it is possible to use immunoselection to selectively
solate cells that are phenotypically identical to E13.5 rat
eural tube-derived NRPs and GRPs. We show that
-NCAM- and A2B5-immunoreactive cells undergo self-
enewal and (in clonal culture) differentiate into neurons or
lial cells, respectively. Furthermore ES cells can be in-
uced to generate NRP and GRP cells similar to those
resent in the developing spinal cord and that these NRPs
nd GRPs can differentiate into functionally mature cells.
e discuss the potential therapeutic application of our
esults.
MATERIALS AND METHODS
Substrate preparation. Fibronectin (Sigma) was diluted to a
concentration of 20 mg/ml in distilled H2O (Sigma). Fibronectin
solution was applied to tissue culture dishes for a minimum of 4 h.
Laminin (Biomedical Technologies Inc.), used at a concentration of
20 mg/ml, was dissolved in Dulbecco’s phosphate-buffered saline
DPBS ,Gibco-BRL). To prepare fibronectin–laminin double-coated
ishes, laminin was applied to fibronectin-coated dishes and plates
ere incubated overnight at 4°C. Excess laminin was withdrawn
nd the plates were rinsed with medium. In some case plates were
recoated with pLL (30–70 kDa) (Sigma Inc.). pLLysine was dis-
olved in distilled water (13.3 mg/ml) and applied to tissue culture
plates for an hour. Excess pLL was withdrawn and the plates were
allowed to air dry. Plates were rinsed with water and then allowed
to dry again. pDL plates were then coated with FN solution or
laminin as described above.
Mouse cell cultures. Mouse C57Bl6 embryos were removed at
embryonic day 9.0 and placed in a petri dish containing DPBS
(Gibco-BRL). The trunk segments of embryos were enzymatically
treated with collagenase (Worthington; 10 mg/ml) and dispase
(Boehringer Mannheim; 20 mg/ml) for 10 min at room temperature.
The enzyme solution was replaced with fresh medium with 10%
chick embryo extract (CEE). The trunk segments were gently
triturated to release the spinal cords from surrounding tissue. The
spinal cords were then incubated in 0.05% trypsin solution for 5
s of reproduction in any form reserved.
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115Neuroblasts and Glioblasts from Mouse Embryosmin at 37°C. The cells were dissociated and plated in 35-mm
fibronectin-coated dishes as mass cultures (5000 cells/dish).Cells
were maintained at 37°C in 5% CO2/95% air in NEP basal medium
see below) and 10% CEE.
Mouse C57B6 embryos were removed at embryonic day 12.0 and
laced in a petri dish containing DPBS. Spinal cords were mechani-
ally dissected from surrounding connective tissue using sharpened
o. 5 forceps. Isolated spinal cords were incubated in 0.05%
rypsin solution for 30 min. The trypsin solution was replaced with
resh medium. The spinal cords were gently triturated with a
asteur pipette to dissociate the cells. The dissociated cells were
lated on fibronectin/laminin-coated dishes. Cells were main-
ained at 37°C in 5% CO2/95% air in NEP complete medium (see
below).
Differentiation into neural crest was promoted by adding bone
morphogenetic protein-4 (BMP-4, 10 ng/ml) to the mouse NEP cells
growing on fibronectin for a period of 4 days. The cells were then
replated on fibronectin/laminin-coated dishes in neural crest me-
dium [NEP basal medium supplemented with bFGF (10 ng/ml),
nerve growth factor (NGF, 50 ng/ml), epidermal growth factor
(EGF, 100 ng/ml)]. All growth factors were obtained from Upstate
Biotechnolgy (Lake Placid, NY) unless otherwise stated. To pro-
mote maturation into Schwann cells, dibutryl cAMP (5 mm/ml,
Sigma) was added for an additional 7 days. To promote smooth
muscle differentiation, crest cells were grown in neural crest
medium supplemented with 10% fetal bovine serum (FBS, Hy-
clone, Logan, UT).
The NEP basal medium used in all experiments was a chemi-
cally defined medium modified from that described by (Stemple
and Anderson, 1992; Kalyani et al., 1997). The medium consisted of
MEM-F12 (Gibco-BRL) supplemented with additives described by
ottenstein and Sato (1979), and bFGF (25 ng/ml, Upstate Biotech-
ology). The NEP complete medium is NEP basal medium with
0% CEE.
ES cell cultures. Undifferentiated ES-D3 cells (ATCC) were
rown as aggregates in suspension dishes (Nunc) in DMEM-F12
ith 10% fetal calf serum (FCS) and leukemia inhibitory factor
LIF, 10 ng/ml, Gibco-BRL) for 4 days. The medium was then
hanged to NEP basal medium and the cells were plated on
bronectin. The medium was changed every 2 days. Differentiation
nto NRPs and GRPs was induced by plating the cells on poly-L-
lysine/laminin double-coated dishes. For long-term neuronal dif-
ferentiation, FGF was withdrawn and retinoic acid (RA, 100 mM,
igma) was added to the medium. Similarly for long-term glial
nduction, cells were maintained in platelet-derived growth factor
PDGF, 10 ng/ml, Upstate Biotechnology) and tri-iodothyronine
ormone (T3, 30 nM, Sigma) with the withdrawal of FGF.
Immunopanning of E-NCAM1 and A2B51 cells. E-NCAM1
and A2B51 cells were purified from dissociated E12.0 neural tube
cells using a specific antibody capture assay (Wysocki and Sato,
1978) with minor modifications. In brief, the cells were trypsinized
and 10 ml of cell suspension (NEP basal medium and 20% FCS) was
plated on a 100-mm petri dish and incubated at 37°C in a 5% CO2
humidified atmosphere for 2–3 h for the maximum attachment of
flat cells. The supernatant, containing an enriched population of
neuronal and oligodendrocyte precursor cells, was plated on dishes
coated with either E-NCAM antibody (5A5, Developmental Stud-
ies Hybridoma Bank (DSHB, 1:1 dilution)) or A2B5 antibody
(ATCC, 1:1 dilution) to allow binding of all E-NCAM1 and A2B51
cells. E-NCAM and A2B5 dishes were prepared by sequentially
coating petri dishes with an unlabeled anti-mouse IgM antibody (10
mg/ml) overnight and rinsing 33 with DPBS, followed by incuba-
tion with E-NCAM or A2B5 hybridoma supernatants for 1–3 hours R
Copyright © 1999 by Academic Press. All rightat room temperature. Cells were allowed to bind to the dish for 1 h
at room temperature. The supernatant was discarded and the dish
was washed 83 with DPBS. The bound cells were mechanically
scraped off and plated on fibronectin/laminin-coated dishes in 1 ml
of NEP basal medium either as mass (5000 cells/dish) or clonal (100
cells/dish) cultures. Growth factors were added every other day. In
all cases, an aliquot of cells was tested for panning efficiency by
immunocytochemistry. In general, the panning efficiency was
greater than 90%. For E-NCAM-panned or NRP cultures, the NEP
basal medium was supplemented with the following growth fac-
tors: NGF, PDGF, brain-derived nerve growth factor (BDNF), and
FGF (all at 10ng/ml). For A2B5-panned or GRP cultures, the NEP
basal medium was supplemented with PDGF (10 ng/ml) and FGF
(10 ng/ml).
Immunocytochemistry. Staining procedures were as described
previously (Rao and Mayer-Proschel,1997). To stain spinal cord
sections embryos were harvested, and either fresh frozen or fixed
embryos (4% paraformaldehyde overnight) were sectioned on a
cryostat to obtain 20-mm sections. These sections were processed
or immunocytochemistry as described below. Staining for the cell
urface markers such as p75, E-NCAM, and galactocerebroside
GalC) was carried out in cultures of living cells without perme-
bilization. To stain cells with antibodies against cytoplasmic
ntigens, cultures were fixed with 2% formaldehyde for 20 min at
oom temperature.
In general, cultured cells or sections were incubated with pri-
ary antibody for 1 h followed by incubation with an appropriate
econdary antibody for 30 min. Double labeling experiments were
erformed by simultaneously incubating cells in appropriate com-
inations of primary antibodies followed by noncrossreactive sec-
ndary antibodies. Bisbenzimide (DAPI) histochemistry was per-
ormed as described previously (Kalyani et al., 1997). Bisbenzimide
Sigma) staining was generally done after labeling had been com-
leted. p75, E-NCAM, and GalC antibodies were hybridoma super-
atants obtained from DSHB. The A2B5 antibody was obtained
rom ATCC. Microtubule-associated protein (MAP2) and b-III
tubulin (Sigma) antibodies, which stain neurons, and nestin (mono-
clonal from DSHB; polyclonal, a kind gift from Dr. Keith Cauley at
Signal Pharmaceuticals), a marker for undifferentiated stem cells
(Zimmerman et al., 1994; Lendahl et al., 1990; Dahlstrand et al.,
995), were used as described previously (Rao and Mayer-Proschel,
997). Antibodies to glutamate and glycine were obtained from
ignature Immunologicals and used as per the manufacturer’s
ecommendations. Antibodies to glial fibrillary acidic protein
GFAP) and glutamate decarboxylase (GAD) were obtained from
hemicon and used at 1:500 dilution.
5-Bromo-2*-deoxyuridine (BRDU) incorporation. To assess the
roliferation of neuronal and oligodendrocyte precursor cells,
RDU (Sigma) at a concentration of 10 mM was added to the cells
for 24 h. The cells were then fixed with 2% paraformaldehyde for
15 min at room temperature followed by 95% methanol for 30 min
at 220°C. Cells were then washed 33 with PBS and 5% goat serum
nd permeabilized with 2 N HCl for 10 min. Acid was removed by
3 washes with PBS and 5% goat serum and the residual HCl was
eutralized with sodium borate (Sigma) for 10 min. After rinsing
ith PBS, cells were incubated with anti-BRDU antibody (1:100,
igma) for 30 min at room temperature in buffer containing 0.5%
riton X-100. The cells were then incubated with goat anti-mouse
gG1 (1:100, Jackson Immunologicals) for 30 min. After three
ashes with PBS, the cells were observed with a Zeiss Fluorescence
icroscope.
RNA extraction, cDNA synthesis, and PCR reactions. TotalNA was isolated from cells or neural tubes by a modification of
s of reproduction in any form reserved.
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116 Mujtaba et al.the guanidinium–isothiocyanate extraction method (TRIzol,
Gibco-BRL). cDNA was synthesized using 10,000 cells or one to
five neural tubes. The amount of first-stand cDNA synthesized was
estimated using a Bioquant fluorometer. Superscript II (Gibco-
BRL), a modified Moloney murine leukemia virus reverse transcrip-
tase. and oligo(dT)12–18 primers were used, and the Gibco-BRL
protocol was followed. Equal amounts of cDNA (in general equiva-
lent to 1/20 of the above reaction) were used in a 50-ml reaction
olume. PCR amplification was performed using Elongase poly-
erase (Gibco-BRL). Primer sequences used for PCR amplification
f receptors are shown in the Table 1 below. The reactions were run
or 35 cycles and a 10-min incubation at 72°C was added at the end
o ensure complete extension. Several controls were run to assure
he fidelity of the reaction. No RT, no primer controls, and positive
ontrols with whole embryo extracts were routinely run alongside
est samples. In cases where levels needed to be estimated samples
ere quantified by running a portion of the amplified product on an
thidium bromide gel and quantifying levels using a Kodak gel
ocumentation and analysis system. To normalize samples and
est for the integrity of cDNA synthesized GAPDH/actin were
mplified in the same tube (or in sister tubes) and levels were
ormalized to the amount of GAPDH/actin. In all cases tests were
un to ensure that samples harvested were from the log phase of
mplification.
Intracellular Ca21 measurements. Calcium imaging experi-
ents were performed on clonal cultures of E-NCAM-panned cells
btained from mouse E12.0 embryos as described above. Cells were
TABLE 1
Gene Product (bp)
p75 329
ChAT 377
Isl-1 350
GAD65 327
Calbindin28 276
Glutaminase 560
Cyclophilin 302
EGF-R 205
FGFR-1 764
FGFR-4 672
PLP/DM20 505/400
MAP2 404
NF-M 186
GFAP 346oaded with 5 mM fura-2 AM (Sigma, Grynkiewics et al., 1985) plus
Copyright © 1999 by Academic Press. All rightpluronic F127 (Sigma, 80 mg/ml) in rat Ringer’s solution (RR, see
elow) at 23°C in the dark. Following the 20-min incubation, cells
ere washed three times in RR and allowed to deesterify for 30
in. Relative changes in intracellular Ca21 concentrations were
measured from the background-corrected ratio of fluorescence
intensity by excitation at 340/380 nm. A response was defined as a
minimum rise of 10% of the ratioed baseline value. A Zeiss-
Attofluor imaging system and software (Atto Instruments Inc.)
were used to acquire and analyze the data. Data points were
sampled at 1 Hz. Neurotransmitters (500 mM concentration) were
made fresh in RR and delivered by bath exchange using a small
volume loop injector (200 ml). RR consisted of (in mM): 140 NaCl,
KCl, 1 MgCl2, 2 CaCl2, 10 Hepes, and 10 glucose. A concentration
of 500 mM ascorbic acid was added to dopamine solutions to
prevent oxidation. Control application of 500 mM ascorbic acid had
o effect (Figs. 5A and 5C). The pH of all solutions was adjusted to
.4 with NaOH. High K RR was made by substituting 50 mM K1
for Na1 in the normal RR.
RESULTS
Stem cells present in the embryonic mouse neural tube
resemble FGF-dependent NEP stem cells isolated from rat
embryos at E10.5. Two kinds of stem cells have been
described in the CNS of developing embryos: an EGF-
Primers sense (top); antisense (bottom)
59 GCA CAT ACT CAG ACG AAG CCA 39
59 AGC AGC CAA GAT GGA GCA ATA GAC 39
59 CTG AAT ACT GGC TGA ATG ACA TG 39
59 AAA TTA ATG ACA ACA TCC AAG AC 39
59 GCA GCA TAG GCT TCA GCA AG 39
59 GTA GCA GGT CCG CAA GGT G 39
59 GAA TCT TTT CTC CTG GTG GTG 39
59 GAT CAA AAG CCC CGT ACA CAG 39
59 GCA GAA TCC CAC CTG CAG - 39
59 GTT GCT GGC ATC GAA AGA G 39
59 GCA CAG ACA TGG TTG GGA TAC TAG 39
59 GCA GGG CTG TTC TGG AGT CG 39
59 CCA CCG TGT TCT TCG ACA TC 39
59 GGT CCA GCA TTT GCC ATG G 39
59 GCT GGG GAA GAG GAG AGG AGA 39
59 ACG AGT GGT GGG CAG GTG TCT T 39
59 TGG GAG CAT CAA CCA CAC CTA CC 39
59 GCC CGA AGC AGC CCT CGC C 39
59 ATC GGA GGC ATT CGG CTG CG 39
59 AGA ACT GCC GGG CCA AAG GG 39
59 GAC ATG AAG CTC TCA CTG GCA C 39
59 CAT ACA TTC TGG CAT CAG CGC 39
59 GAA GGA AAG GCA CCA CAC TG 39
59 GCT GGC GAT GGT GGT GGG 39
59 GCC GAG CAG ACC AAG GAG GCC ATT 39
59 CTG GAT GGT GTC CTG GTA GCT GCT 39
59 TTG CAG ACC TCA CAG ACG CTG CGT 39
59 CGG TTT TCT TCG CCC TCC AGC AAT 39dependent stem cell present in more cranial portions of the
s of reproduction in any form reserved.
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117Neuroblasts and Glioblasts from Mouse Embryos
Copyright © 1999 by Academic Press. All rightneural tube (Santa-Ollala and Covarrubias, 1995; Reynolds
et al., 1992; Weiss et al., 1996a) that grows in suspension
culture and a FGF and/or FGF/EGF-dependent stem cell
that is present in more caudal neural tube (Kalyani et al.,
1997; Weiss et al., 1996a,b) as well as in the cortex (Palmer
t al., 1995; McKay, 1997). Both stem cells have been shown
o be present at later developmental stages, but the proper-
ies of the stem cells present at early stages of mouse
eurogenesis remain to be determined.
To characterize the earliest mouse NEP precursor cells,
e examined the antigenic properties, growth characteris-
ics, and differentiation potential of stem cells present at
he time of neural tube closure. E9 mouse neural tubes were
solated as previously described (Rao and Anderson, 1997;
ee also Materials and Methods) and cells were plated at low
ensity to test the growth characteristics of NEP stem cells.
EP cells appeared homogenous and were nestin immuno-
eactive. Many cells (.70%) incorporated BRDU over a 6-h
eriod indicating that they were actively dividing cells
hen maintained in 25 ng/ml of FGF (Fig. 1A). NEP cells
id not express any markers of early as tested by either
mmunocytochemistry or RT-PCR differentiation (Figs. 1D
nd 2A, lanes 2, 4, and 6). In particular, NEP cells did not
xpress E-NCAM, b-III tubulin, or A2B5 immunoreactivity
(Fig. 1D) indicating that they were undifferentiated precur-
sor cells. Nestin-immunoreactive cells persisted around the
ventricular zone at E10 (Fig. 1C) while b-III tubulin-
immunoreactive neurons appeared to differentiate at the
ventricular margins (Fig. 1C).
To determine the growth factor dependence of E9 NEP
cells, several growth factors were tested at a variety of
different concentrations (Fig. 1E). FGF was sufficient to
maintain NEP cell proliferation. In particular, NGF, PDGF,
and EGF were ineffective at any dose tested. None of the
growth factors tested (Fig. 1F) acted synergistically with
FGF to alter cell division rates (Fig. 1F) suggesting that EGF
and PDGF were neither survival or proliferation factors for
NEP cells. The failure to see a response to EGF indicated
that these cells were distinct from both the EGF-dependent
neurospheres and the FGF/EGF-dependent cells isolated
from later stages in the spinal cord (Reynolds et al., 1992;
Reynolds and Weiss, 1996; Weiss et al., 1996a,b). To con-
firm the similarity between E9.0 mouse NEP cells and
previously characterized rat neuroepithelial stem cells, we
examined EGF-R expression in our cultures. As can be seen
in Fig. 2 we failed to detect EGF-R in mouse NEP cells by
zone. D, summarizes the antigenic profile of nestin-
immunoreactive NEP cells in vitro and in vivo (section staining).
Mouse NEP cells at this stage express nestin and are immunonega-
tive for all lineage markers tested. E, shows the concentration range
of various growth factors tested. Dose–response curves in F show
that bFGF alone (at 10 ng/ml) is sufficient to induce a maximal
proliferative effect while PDGF, EGF, and NGF have no additive
effect. All experiments were run in duplicate and repeated threeFIG. 1. Mouse spinal cord NEP cells are nestin-immunoreactive
GF-dependent cells. E10 mouse neural tubes were sectioned (C
nd D) or E9 neural tube cells were dissociated and plated onto
5-mm fibronectin-coated dishes at low density in NEP basal
edium with bFGF alone (A, A9, B, B9) or in combination with
different growth factors (E and F). Cells were allowed to grow
overnight, pulsed with BRDU for 6 h, and processed for nestin
expression (B and B9), BRDU incorporation (A, A9, and F), and
markers of differentiation (D). As can be seen in A (red) and A9
phase) cells have divided in culture. Panel B (green) and B’ (phase)
how that all cells express nestin immunoreactivity. C, a trans-
erse section of an E10 mouse embryo neural tube double labeled
ith antibodies against mouse monoclonal nestin (green) and
ouse monoclonal b-III tubulin (red). Note that nestin positivetimes with five random fields counted in each dish.
s of reproduction in any form reserved.
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118 Mujtaba et al.PCR. In contrast, EGF-R was readily detected in whole
brain (Fig. 2B) as well as on glial precursors, neurons, and
astrocytes (Fig. 2B and data not shown). Identical results
were obtained using an antibody specific to mouse EGF-R
(data not shown). Thus, mouse NEP cells appeared more
similar to rat NEP cells as described previously by Kalyani
FIG. 2. Mouse spinal cord NEP cells are undifferentiated cells
that express FGFRs but do not express EGFRs. RNA isolated from
mouse neural tubes at E9, dissociated cells at E12, and rat NEP cells
at E10.5 was reverse transcribed as described under Materials and
Methods to obtain cDNA. Equal concentrations of the resulting
cDNA (10 ng/reaction) were used for PCR analysis using primers
listed in Table 1. PCR products were resolved on a 2% agarose gel
and single bands of appropriate sizes were detected. A, shows that
E9 mouse NEP cells do not express MAP-2 (lane 2) or GFAP (lane
4) and express a single band of DM-20 (lane 6). In contrast these
markers are readily detected in differentiated cells (lanes 3, 5, and
7, respectively). Note that both PLP and DM-20 are expressed by
differentiated cells (compare lane 6 and lane 7). Lane 1 shows that
no amplification is seen when primers are omitted from the PCR
reaction and lane 8 shows that cyclophilin can be readily amplified
from E9 cDNA indicating the integrity of the cDNA. Thus PCR
amplification confirms the immunocytochemical analysis demon-
strating that NEP cells do not express any neuronal or glial
markers. Controls for the PCR analysis are described under Mate-
rials and Methods. E9 neural tube cDNA was also used to test for
expression of EGF and FGF receptors (B). FGFR1 and FGFR4 were
readily detected in mouse NEP cells (lane 5 and lane 7). In contrast
no EGF-R expression was seen (lane 4). EGF-R expression, however,
was readily detected in rat brain (lane 1) and mouse glial cells (lane
3) which were run in parallel demonstrating the sensitivity of the
amplification reaction. Comparison of mouse NEP cell cDNA with
rat NEP cell cDNA shows that the profile of EGF and FGF receptor
expression is similar (compare lanes 4, 5, and 7 with lanes 2, 6, and
8, respectively). Thus mouse NEP cells like rat NEP cells express
FGFRs but not EGFRs.et al. (1997) and were distinct from EGF-dependent mouse
Copyright © 1999 by Academic Press. All righteurospheres as well as FGF/EGF-dependent mouse stem
ells isolated at later stages of development.
E9.0 mouse NEP cells could be maintained in NEP basal
edium with the addition of FGF for several passages (at
east 10) and could then be induced to differentiate by
eplating the cells on laminin or poly-L-lysine and reducing
FGF concentrations. NEP cells under these conditions
readily differentiated into neurons, astrocytes and oligoden-
drocytes (Figs. 3A–3D). Clonal analysis of mouse NEP cells
(N 5 65) confirmed that individual cells (N 5 40 or 61%)
were multipotent and that a single cell could generate
neurons, astrocytes, and oligodendrocytes. Thus, like rat
NEP cells, mouse NEP cells are FGF dependent, grow in
adherent culture, and can generate CNS derivatives. To
further confirm the similarities between mouse and rat
NEP cells we asked if mouse NEP cells could generate
neural crest derivatives. We have shown previously that rat
NEP cells can generate neural crest stem cells either sto-
chastically or in response to the addition of BMP-2 or
BMP-4 (Mujtaba et al., 1998). As can be seen in Fig. 3,
mouse NEP cells generate p75-immunoreactive crest cells,
smooth muscle actin (SMA)-immunoreactive smooth
muscle cells that coexpress desmin immunoreactivity but
do not express GFAP immunoreactivity and peripheral glia
(Schwann cells) and neurons (Figs. 3E and 3G and data not
shown). PCR analysis also confirms an increase in the
expression of p75 (Fig. 3F) as described for rat NEP cells
(Mujtaba et al., 1997), when NEP cells are induced to
differentiate into neural crest by the addition of 10 ng/ml of
BMP-4. Neural crest and its derivatives have not been
generated from EGF-dependent stem cells (reviewed in
Kalyani and Rao, 1999). Thus, the developing mouse neural
tube contains nestin-immunoreactive, FGF-dependent plu-
ripotent cells that resemble rat NEP cells, rather than
EGF-dependent neurosphere stem cells.
Lineage-restricted neuronal precursors exist in the de-
veloping mouse spinal cord. We have previously shown
that differentiation in rat neural tubes involves progressive
restriction of cell fate (reviewed in Kalyani and Rao, 1999).
NEP cells generate more restricted (but still multipotent)
precursors both in vitro and in vivo (Mayer-Proschel et al.,
1997; Rao et al., 1998). Two such restricted multipotent
precursors have been described: an E-NCAM-
immunoreactive neuronal precursor (Mayer-Proschel et al.,
1997; Kalyani et al., 1998) and an A2B5-immunoreactive
glial precursor (Rao and Mayer-Proschel, 1997; Rao et al.,
1998). To determine if similar neuronal precursors could be
isolated from mouse neural tubes, we analyzed E12.0
mouse neural tubes for the presence of E-NCAM-
immunoreactive cells. A significant proportion of E12.0
neural tubes cells were E-NCAM immunoreactive (ranging
from 70 to 80% in three independent experiments). Immu-
noselected E-NCAM1 cells divided in culture (Fig. 4A) and
xpressed neuronal but not glial markers (table in Fig. 4).
-NCAM1 cells could be maintained as a dividing popula-
tion of cells for a period of a month (data not shown) when
grown in FGF (10 ng/ml), NGF (10 ng/ml), PDGF (10 ng/ml),
s of reproduction in any form reserved.
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Copyright © 1999 by Academic Press. All rightand BDNF (10 ng/ml). Thus, based on their antigenic
profile, E-NCAM-immunoreactive cells appeared to be di-
viding neuronal precursor cells (Fig. 4A). To test the differ-
entiation potential of E-NCA-immunoreactive cells, puri-
fied populations of E-NCAM1 cells were analyzed in mass
nd clonal culture. E-NCAM1 cells, when allowed to dif-
erentiate by addition of retinoic acid and reduction of FGF
oncentration, readily differentiated into multiple kinds of
eurons as assessed by RT-PCR (Fig. 4D) and immunocyto-
hemistry (data not shown). However, E-NCAM-
mmunoreactive cells failed to differentiate into either
ligodendrocytes or astrocytes when grown under glial
romoting conditions, indicating that these cells are lim-
ted in their differentiation potential. Glial promoting con-
itions tested included and addition of T3 and PDGF or
0% fetal calf serum, conditions under which A2B5 immu-
oselected cells or NEP cells readily generated glial deriva-
ives (Figs. 3 and 6 and data not shown).
To examine the ability of differentiated E-NCAM1 cells
o respond to neurotransmitters and elevated K1, we used
ura-2 Ca21 imaging techniques. E12.0 E-NCAM1 cells were
rown in culture for 10 days and allowed to differentiate.
hey were then loaded with fura-2 (see Materials and
ethods) and the changes in internal Ca21 concentrations
in response to stimulus application were monitored. Figure
5A shows a bar graph of the number of cells (sum of cells
from two independent experiments) responding to applica-
tion of the indicated neurotransmitter. Most cells (.95%)
responded to external application of glutamate or acetyl-
choline. Smaller fractions of cells responded to dopamine,
GABA, or glycine. A substantial fraction of the cells re-
sponded to more than one neurotransmitter (summarized in
Fig. 5B) demonstrating heterogeneity in the neuronal popu-
lation derived from E-NCAM1 precursors. Representative
traces of internal Ca21 changes plotted over time are shown
for two different cells from the same clonally derived
culture (Fig. 5C). While both cells responded to glutamate,
acetylcholine, and high K1, the cell in the lower trace also
responded to dopamine, indicating that the receptor expres-
sion profile of cells in the same culture varies. Thus
E-NCAM-immunoreactive cells are neuronal-restricted
precursor cells that can differentiate into a heterogeneous
population of neurons and closely resemble their rat coun-
terparts in antigenic characteristics, differentiation proper-
ties, and growth potential.
Lineage-restricted glial precursors exist in the develop-
ing mouse spinal cord. To determine if A2B5 immunore-
activity could be used to isolate glial precursors at early
stages of embryonic development, we isolated A2B5-
immunoreactive cells by immunopanning and mass cul-
green, respectively, G and G9). NEP cells differentiated into SMA/
desmin-immunoreactive smooth muscle cells (G and G9) that did
not express GFAP (F). Thus, NEP cell cells can differentiate intoFIG. 3. Mouse NEP cells can differentiate into neurons, astro-
cytes, and oligodendrocytes. E9 mouse NEP cells grown on fi-
bronectin for 5 days were harvested by trypsinization and replated
onto fibronectin/laminin-coated dishes in NEP medium without
CEE for a period of 5–10 days. Some culture dishes were then
processed for labeling with b-III tubulin (red, A and B), A2B5 (green,
), GalC (red, C), and GFAP (green, D). Other culture dishes were
xposed to BMP-4 (10 ng/ml) for 4 days. The cells were then
eplated on fibronectin/laminin-coated dishes in neural crest me-
ium (see Materials and Methods) and were allowed to differentiate
or an additional period of 5 (E and F) or 10 days (G and H). Cells
ere then processed for the expression of specific markers by either
T-PCR (H) or immunocytochemistry for expression of p75 (red, E),
MA/GFAP (red/green, respectively, F) and SMA/desmin (red/
reen, respectively, G and G9). NEP cells could differentiate into
b-III-immunoreactive neurons (A), A2B5-immunoreactive/b-III
tubulin-negative glial precursors (B), GalC-immunoreactive oligo-
dendrocytes (C), and GFAP-immunoreactive astrocytes (D). Double
labeling with A2B5 and b-III tubulin (B) shows that a small subset
of b-III tubulin1 are also A2B51 cells (B, arrowhead). These cells
were excluded from subsequent analysis (see Results for a detailed
discussion). NEP cells can also generate neural crest cells in culture
when exposed to BMP (E and F). Note the large number of
p75-immunoreactive cells (E) and the increased expression of p75
relative to cyclophilin when NEP cells are exposed to BMP-2 (H).
p75-immunoreactive cells did not express neuronal or glial markers
at this stage (unpublished results). NEP cells cultured for 10 days in
neural crest medium supplemented with 10% FBS were stained forboth CNS and PNS cells.
s of reproduction in any form reserved.
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Copyright © 1999 by Academic Press. All righttures of cells were tested for cell division by BRDU incor-
poration. A2B5-imunoreactive cells (Fig. 6A) had divided in
culture, indicating that these are a mitotic population. We
further examined the antigenic properties and differentia-
tion potential of these cells and noted one important
difference between rat and mouse A2B5-immunoreactive
cell cultures: a small subset of the mouse A2B5-
FIG. 5. Differentiated E-NCAM1 cells show heterogeneous re-
ponses to neurotransmitters. Ca21 imaging experiments using
ura-2 showed that cell populations from two different mouse
-NCAM1 clones express different percentages of neurotransmitter
eceptors. The bar graph (A) shows the percentage of cells respond-
ng to 500 mM GABA, glycine (Gly), dopamine (DA), ascorbic acid
AA), L-glutamate (Glu), acetylcholine (ACh), betaine (Bet), and 50
M K1 (high K). The red bars represent 95 cells from clone 1 and
the blue bars represent 99 cells from clone 2. Pie charts (B) show the
percentage of cells that responded to one or specific combinations
of neurotransmitters. The left and right graphs correspond to cells
from clones 1 and 2, respectively. Cells from clone 1 showed
more heterogeneity than clone 2. The ratio of intensity from
excitation at 340 and 380 nm plotted over time shows that Ca21
responses to neurotransmitters differ in two different cells from the
same clone (C).FIG. 4. E-NCAM-immunoreactive cells are neuron-restricted pre-
cursor (NRP) cells. E12.0 mouse neural tube cells were immunos-
elected for E-NCAM expression. The immunoselected cell population
was plated on fibronectin/laminin-coated dishes at medium density
in NEP medium supplemented with FGF (10 ng/ml), PDGF (10
ng/ml), BDNF (10 ng/ml), and NT-3 (10 ng/ml) which were added to
cultured cells at day 2 for a period of 24 h. Cells were then stained for
E-NCAM expression (green) and BRDU incorporation (red). Immunos-
elected cells were E-NCAM1 and a subset of cells had divided and
incorporated BRDU within 24 h (A). B, lists the antigenic profile of
acutely dissociated E-NCAM-immunoreactive cells. Note that
E-NCAM1 cells express some neuronal markers and do not express
lial markers. An example of coexpression of a neuronal marker
AP-2 (C9) with E-NCAM (C) is shown. Most E-NCAM1 cells are
MAP21. Some of the cultures were allowed to mature for an addi-
tional 10 days and then processed for PCR analysis. Controls for the
PCR analysis are described under Materials and Methods. D, shows
the presence of mature neuronal markers upon differentiation. These
1 immunoreactive cells (,5%) were b-III tubulin immunore-
s of reproduction in any form reserved.
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121Neuroblasts and Glioblasts from Mouse Embryosactive (Fig. 3B). This population was also E-NCAM immu-
noreactive as determined by immunopanning experiments
(data not shown). Thus unlike rat spinal cord cultures, the
A2B5 epitope was not uniquely present on glial cells. To
determine if the E-NCAM/b-III tubulin-negative subset of
A2B5 cells represented glial precursors, we isolated this
population by sequential panning. E-NCAM-immunoreac-
FIG. 6. A2B51/E-NCAM2 cells express DM-20 and can differen-
tiate into oligodendrocytes and two types of astrocytes. E12.0
mouse neural tube cells were sequentially immunopanned for
E-NCAM and A2B5 to obtain A2B51/E-NCAM2 cells. A2B51/E-
NCAM2 cells were plated on fibronectin/laminin-coated dishes in
NEP basal medium and their mitotic ability (A), antigenic proper-
ties (B and C), and ability to differentiate (D–F) were tested. BRDU
was added to some cultures on day 2 for a period of 24 h and cells
were processed for BRDU incorporation (A, red). Note that immu-
nopanned cells are A2B51 and a subset has divided within 24 h (A).
ister plates of cells were either fixed and processed for immuno-
ytochemistry (B) or RNA harvested for RT-PCR analysis (C). The
hart (B) summarizes the antigenic profile of undifferentiated
2B5-immunoreactive cells which are A2B51 and nestin1 at this
tage and immunonegative for all neuronal and astrocytic markers
ested. RT-PCR analysis (C) confirms the immunocytochemistry
esults and shows that A2B51/E-NCAM2 cells do not express NF,
GFAP, or PLP but do express DM-20 (see Results for a detailed
discussion). To test the ability of A2B51/E-NCAM2 to differentiate
into oligodendrocytes and astrocytes cells A2B51/E-NCAM2 cells
ere grown in medium containing ciliary neurotrophic factor
CNTF, 10 ng/ml), 10% FCS, or PDGF (10 ng/ml) for a period of
–14 days (D–F, respectively) and labeled for A2B5 expression
green, D and E), GFAP expression (red, D and E), and GalC
xpression (red, F). 50% of the A2B51/E-NCAM2-derived cells
grown in CNTF differentiated into A2B51 process-bearing astro-
cytes (D), while the others were A2B52 fibroblast-looking astro-
ytes. The cells exposed to 10% FCS differentiated into A2B52/
GFAP1 astrocytes (E). Exposure to PDGF/T3 resulted in mature
looking oligodendrocytes most of which were GalC1 (F). Thus,
A2B51/E-NCAM2-immunoselected cells can generate oligodendro-
ytes and two kinds of astrocytes.tive cells were isolated and discarded and the E-NCAM- s
Copyright © 1999 by Academic Press. All rightmmunonegative population was repanned to isolate the
2B5-immunoreactive cells. Pooled A2B51/E-NCAM2 cells
ere analyzed by PCR and immunocytochemistry; the
esults are summarized in Fig. 6.
A2B51/E-NCAM2 cells were nestin immunoreactive (Fig.
6) and did not express neuronal markers or markers of
differentiated glial cells (Figs. 6B and 6C). A2B51/E-
NCAM2 cells however could differentiate into oligodendro-
cytes and two kinds of astrocytes (Figs. 6D–6F) but failed to
differentiate into neurons when grown under neuron pro-
moting conditions, indicating that these cells are limited in
their differentiation potential. Thus glial-restricted and
neuronal-restricted precursors are present in the developing
mouse spinal cord and these precursor cells can be distin-
guished by E-NCAM and A2B5 immunoreactivity.
ES-cell-derived E-NCAM cells are neuron-restricted pre-
cursor cells similar to E12.0 NRPs. ES cells have been
shown to be capable of differentiating into neurons, astro-
cytes, and oligodendrocytes. More recently Okabe et al.
(1996) and Li et al. (1998) have shown that NEP-like cells
can be harvested from ES cells, bypassing the need to
harvest stem cells from fetal tissue. To determine if more
restricted neural precursors that appear at developmentally
later embryonic stages could be harvested similarly, we
analyzed ES cell cultures. The ES-D3 cell line which has
been shown to be able to contribute to all cell lineages was
obtained from ATCC and grown in nondifferentiating (as
aggregates in DMEM/F12, 10% FCS, and LIF 10 ng/ml) and
differentiating conditions (as adherent cultures on
polylysine/laminin substrate in NEP basal medium). Undif-
ferentiated ES cells did not express E-NCAM immunoreac-
tivity (Fig. 7A) but upon aggregation and treatment with RA
(1mM), a subset (approx. 5%) of cells began to express
-NCAM immunoreactivity (Fig. 7B). E-NCAM1 cells were
mitotic population as assessed by BRDU incorporation
Figs. 8A and 8B). E-NCAM cells coexpressed MAP2, a
arker for neurons (DeCamilli et al., 1984) and b-III tubu-
in immunoreactivity, but did not express GFAP, GalC, or
4 immunoreactivity (Figs. 7C, 7C9, 7D, 7D9, and 7F and
ata not shown). A subset of the E-NCAM cells were nestin
mmunoreactive (Fig. 7E) but none of the cells expressed
FAP, a glial marker (Fig. 7F). The coexpression of neuronal
arkers with E-NCAM and the absence of glial markers
uggest that ES-cell-derived E-NCAM-immunoreactive
ells are similar to E12.0 mouse neuronal-restricted precur-
or cells.
To further confirm the neuronal differentiation of ES-
ell-derived E-NCAM cells, ES cells were induced to differ-
ntiate and E-NCAM-immunoreactive cells were selected
y immunopanning. Cells were grown in mass (Fig. 8) or
lonal culture (data not shown) in medium supplemented
ith FGF and NT-3. When mass cultures of E-NCAM cells
ere induced to differentiate by withdrawal of FGF and the
ddition of RA, cells became postmitotic (data not shown),
laborated extensive processes, and synthesized multiple
eurotransmitters. Immunocytochemistry and PCR analy-
is show the presence of various excitatory, inhibitory, and
s of reproduction in any form reserved.
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Copyright © 1999 by Academic Press. All rightcholinergic neurotransmitters after differentiation (Fig.
8C–8E and PCR profile). E-NCAM-immunoreactive cells
failed to differentiate into either oligodendrocytes or astro-
cytes when grown under glial promoting conditions, indi-
FIG. 8. ES-cell-derived E-NCAM-immunoreactive cells express
mature neuronal markers upon differentiation. ES-D3-derived
E-NCAM1 cells were isolated by immunopanning, plated on
fibronectin-coated dishes, and pulsed with BRDU for 24 h. Note
that within 24 h, a significant proportion of the E-NCAM1-panned,
b-III tubulin-immunoreactive cells (B) had incorporated BRDU (A).
Cultured cells were allowed to differentiate for 10 days and were
then analyzed by RT-PCR or by immunocytochemistry. Differen-
tiated E-NCAM1 cells were fixed and stained with antibodies to
glutamate (C and C9), GAD (D and D9), and glycine (E and E9). Phase
(C9, D9, and E9) and bright-field (C–E) images of representative fields
show staining with each antibody. Subsets of E-NCAM1 neurons
xpressed each marker, the proportions of which differed between
ntibodies [note both the presence (straight arrow) and the absence
curved arrow) of staining in different cells of the same population].
he PCR panel shows the expression of various mature neuronal
arkers tested. Thus, ES-cell-derived, E-NCAM1 cells, which do
not express mature neuronal markers (data not shown) when
undifferentiated, begin to express neurotransmitter-synthesizing
enzymes or mature phenotypic markers upon differentiation in
culture.FIG. 7. ES cells express early neuronal markers upon differen-
tiation. ES-D3 cells were grown as aggregates for 4 days and then
plated on fibronectin-coated dishes in NEP basal medium. To
allow differentiation, the cells were replated on polylysine/
laminin and were grown in NEP basal medium. The cells were
processed for DAPI histochemistry (blue, A and B) and E-NCAM
expression before and after differentiation. A, shows the absence
of E-NCAM immunoreactivity in undifferentiated ES cells. After
differentiation, the cells expressed E-NCAM immunoreactivity
(B). The E-NCAM-labeled cells (red, C and D) were double
labeled with b-III tubulin and MAP2 (green, C9 and D9, respec-
tively). Note that all the E-NCAM1 cells are also b-III tubulin1
and MAP21. Differentiated cell cultures were also stained with
antibodies to nestin (green) and GFAP (green, E and F, respec-
tively). Staining showed that a subset of E-NCAM1 cells express
nestin immunoreactivity (E) but these cells do not coexpress
GFAP immunoreactivity (F). Thus ES-cell-derived E-NCAM1
cells resemble neuron-restricted precursors isolated from mouse
cating that these cells are limited in their differentiation
s of reproduction in any form reserved.
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Copyright © 1999 by Academic Press. All rightpotential. Thus ES cells can be used as a source of neuronal-
restricted precursor cells.
ES-cell-derived A2B51/E-NCAM2 cells are self-renewing
lial-restricted stem cells. To test the differentiation po-
ential of A2B51/E-NCAM2 cells, ES cells were induced to
differentiate and E-NCAM-immunoreactive cells were de-
pleted by immunopanning. E-NCAM-immunonegative
cells were reselected for A2B5 immunoreactivity. This
double selection procedure was utilized as described above
because in mice, A2B5 immunoreactivity has been detected
on glial precursors, as well as on subsets of neurons (Eisen-
barth et al., 1979). A2B5-immunopositive cells were grown
in mass or clonal culture in medium supplemented with
FGF and PDGF. These two factors were used because
preliminary results had shown that both molecules are
required to maintain A2B5-immunoreactive cells in a pro-
liferative state. A2B5-immunoreactive cells expressed nes-
tin but did not express neuronal markers such as b-III
tubulin or glial markers such as GFAP or GalC. When mass
cultures of A2B51/E-NCAM2 cells were induced to differ-
entiate by withdrawal of FGF, cells differentiated into
different glial populations. Two kinds of astrocytes could be
identified as early as 7 days after induction of differentia-
tion: an A2B52/GFAP1 flat astrocyte which appeared simi-
ar to astrocytes previously characterized as Type 1 astro-
ytes and a A2B51/GFAP1 astrocyte which appeared similar
o type 2 astrocytes (Figs. 9E and 9F). In addition, if cells
ere allowed to differentiate for longer time periods (10
ays), oligodendrocyte differentiation could be detected
Fig. 9G) as assessed by GalC immunocytochemistry. A2B5-
mmunoreactive cells failed to differentiate into neurons
data not shown) when grown under neuron promoting
onditions, indicating that these cells are limited in their
ifferentiation potential to glial lineages. The ability of
S-cell-derived A2B5-immunoreactive cells to differentiate
nto astrocytes and oligodendrocytes confirms their resem-
lance to E12.0 A2B5-derived GRP cells and suggests that
ike neuron-restricted precursors, glial-restricted precursors
an be isolated directly from differentiating ES cell cultures.
DISCUSSION
We have shown that NEP cells, neuroblasts, and glio-
blasts are present in the developing mouse spinal cord. The
characteristics of mouse CNS precursor cells are similar to
those described for rat precursors and differ from previously
described neurosphere cells. E-NCAM and A2B5 immuno-
reactivity can be used to isolate restricted neuronal and
glial precursors both from the mouse spinal cord and from
analyzed by PCR. H, shows the PCR profile of differentiated
ES-cell-derived A2B51 cells. Note the strong expression of PLP/
M-20 (lane 2) and GFAP (lane 4, an astrocytic marker) and theFIG. 9. ES-cell-derived A2B5-immunoreactive cells differentiate
into oligodendrocytes and two types of astrocytes. ES-D3 cells were
plated on fibronectin/laminin-coated dishes in NEP basal medium
and were allowed to differentiate for 5 days. The cells were then
labeled with A2B5. Note the absence of A2B5 immunoreactivity in
undifferentiated cells (A) and the presence of A2B51 cells in culture
after differentiation (red, B). The A2B51 cells were immunopanned
and a purified population isolated (C and C9). Note that all
DAPI-stained nuclei, representing the total number of cells present
in the field (C9) are A2B51 (C). A2B51 cells were either fixed and
rocessed for immunocytochemistry (D) or allowed to differentiate
E–H). Undifferentiated cells expressed nestin immunoreactivity
ut did not show detectable levels of GFAP, b-III tubulin, neuro-
filament, or GalC immunoreactivity and thus resembled mouse
neural tube-derived glial precursors. To promote differentiation
ES-cell-derived A2B51 cells were plated on polylysine/laminin-
coated dishes and were grown in NEP basal medium supplemented
with 10% FCS (E), CNTF (10 ng/ml, F), or PDGF (10 ng/ml, G and
H) for 7–14 days and then labeled with antibodies to A2B5 (green,
E and F), GFAP (red, E and F), and GalC (red, G) antibodies. The
cells exposed to FCS differentiated almost entirely into A2B52
astrocytes with a fibroblast-looking morphology (E). 50% of the
GRP cells exposed to CNTF differentiated into A2B51 process-
earing astrocytes, while the others were A2B52 astrocytes (F).
xposure to PDGF resulted in mature looking oligodendrocytes
hich were immunoreactive for GalC (G). The A2B51 ES cells were
rown on polylysine/laminin in NEP basal medium supplemented
bsence of neurofilament (lane 3, a neuronal marker).
s of reproduction in any form reserved.
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124 Mujtaba et al.mouse ES cell cultures. E-NCAM-immunoreactive cells
present in populations of differentiated ES cells have lost
the ability to generate astrocytes or oligodendrocytes, but
retain the ability to generate multiple neuronal phenotypes.
ES-cell-derived, A2B5-immunoreactive GRP cells do not
differentiate into neurons, but instead differentiate into
oligodendrocytes and astrocytes.
An important observation was that the properties of
mouse NEP cells resembled those of rat NEP cells rather
than other classes of stem cells previously described (Kil-
patrick and Bartlett, 1995; Gritti et al., 1996; Johe et al.,
996; Weiss et al., 1996a,b). Mouse NEP cells grew in
dherent culture, did not express EGF-R immunoreactivity,
ould not survive or proliferate in EGF, and absolutely
equired FGF for both proliferation and survival. PDGF,
hich has been shown to be an instructive molecule for
ortical stem cells (Williams et al., 1997; Lachyankar et al.,
997), had no observable effect either alone or in combina-
ion with FGF. Our results are consistent with recent
eports showing that FGF2 injections in vivo will increase
he progenitor pool and that the ventricular zone is reduced
n mice lacking FGF2 (Vaccarino et al., 1999) and with
arlier reports showing expression of FGFRs in the ventric-
lar zone (see for example Orr-Urteger et al., 1991). Our
esults also show that EGF is not a mitogen for NEP cells
nd that EGF-R is not expressed or expressed at low levels
arly in development. These results are consistent with
eports of EGF-R expression in vivo (Adamson and Meek,
984; Lazaar and Blum, 1992; Burrows et al., 1997) and the
functional effects seen in EGF-R knockouts. Transgenic
animals lacking EGF-R show no observable deficit in ven-
tricular zone stem cells but do show deficits in neuronal
migration (Miettinen et al., 1995; Threadgill et al., 1995).
hus, our data suggest that at least during early time
eriods of development, only FGF-dependent pluripotent
tem cells are present in the developing spinal cord. Taken
ogether with evidence that at later stages an EGF- or
GF/FGF-dependent cell is present (see for example Gritti
t al., 1999), we suggest that at least two classes of stem
ells exist. Recent reports suggest that the FGF-dependent
tem cell may be the precursor of the EGF-dependent stem
ell (Ciccolini and Svendsen, 1998; Tropepe et al., 1999).
hese reports, together with our observation that the early
GF-dependent stem cell does not express EGF-R immuno-
eactivity, identify EGF-R as a marker that can be used to
elect between these two populations of stem cells.
Our results also show that E-NCAM and A2B5 immunore-
ctivity can be used to isolate lineage restricted precursor
ells. E-NCAM appears to be expressed exclusively by neuro-
al precursors at this stage (E12.0) in development. Neither
EP cells nor glial precursors express detectable levels of the
-NCAM epitope recognized by the 5A5 antibody. E-NCAM-
mmunoreactive cells appear capable of generating multiple
inds of neurons as demonstrated by immunocytochemistry,
CR, and Ca21 imaging. The Ca21 imaging experiments
learly indicate that cells are functionally heterogeneous and
an respond to multiple classes of neurotransmitter signals.
Copyright © 1999 by Academic Press. All rightouse E-NCAM cells appear similar to the rat-restricted
euronal precursors (Gensburger et al., 1987; Ray et al., 1993;
Ray and Gage, 1994; Mayer-Proschel et al., 1997). Both mouse
and rat cells are E-NCAM immunoreactive, proliferate in
response to FGF-1 and –2, and can differentiate into multiple
classes of neurons. We have however noted some small
differences in proliferation and differentiation potential. Rat
NRP cells appear more robust and survive over multiple
passages, while mouse NRPs appear more fragile and we have
been unable to maintain them for more than 10–12 passages
(data not shown). Rat cells appear to be more heterogeneous as
assessed by Ca21 imaging (Kalyani et al., 1998), while mouse
ells show less heterogeneity (present results) and appear to
ature more slowly. It remains to be determined whether
ifferences in culture requirements underlie these differences
r whether fundamental differences exist. It is interesting to
ote that while mouse ES cells have been readily obtained, rat
S cells have not been developed successfully.
Our results show that A2B5 immunoreactivity is not
xclusive to glial precursors at this stage (E12.0). A small
roportion of neuronal cells (,5%) express A2B5 immuno-
eactivity. We have not analyzed this subpopulation al-
hough morphologically they do not appear to be distinct
rom other neuronal cells. When the A2B51/E-NCAM2
population of cells is excluded by prepanning for E-NCAM-
immunoreactive cells, the remaining population appears to
be restricted to glial differentiation. This A2B5-
immunoreactive glial precursor is distinct from the more
restricted A2B5-immunoreactive O-2A precursor (oligoden-
drocyte type 2 astrocyte precursors, reviewed in Mayer-
Proschel et al., 1997) and appears similar to rat GRP cells.
Like rat GRP cells, mouse GRPs generate oligodendrocytes
and two kinds of astrocytes (A2B51/GFAP1 and A2B52/
FAP1). Like rat GRPs and unlike O-2A cells, mouse GRPs
espond to CNTF by differentiating into astrocytes rather
han oligodendrocytes (Rao et al., 1998; data not shown).
hus, mouse GRPs resemble their rat counterparts and are
resent at corresponding times of development (see results
nd unpublished observations).
To determine if NRP and GRP cells can be isolated
irectly from ES cells differentiated in vitro, we tested a
ariety of differentiation protocols (data not shown). We
ave described an experimental paradigm in which totipo-
ent embryonic stem cells generate restricted neuronal and
lial precursors and have shown that E-NCAM and A2B5
mmunoreactivity is sufficient to purify ES-cell-derived
euroblasts and glioblasts. ES-cell-derived NRPs and GRPs
re morphologically and phenotypically identical to the
euroblasts and glioblasts that we have described as being
resent in E12.0 mouse embryos. Like E12.0 precursor cells,
S-cell-derived NRPs are dividing cells that are limited in
heir differentiation into neurons. Multiple kinds of neu-
ons are generated. In particular, glutamatergic, GABAergic,
nd cholinergic neurons could be identified by PCR and
mmunocytochemistry (see results). Likewise, ES-cell-
erived A2B51 glial precursors resembled E12.0 GRPsrather than O-2A or other glial precursors. Our data suggest
s of reproduction in any form reserved.
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125Neuroblasts and Glioblasts from Mouse Embryosthat ES cells can serve as a source of more downstream,
more restricted precursor cells. Since ES cells can be readily
maintained in vitro, these cells serve as a ready source of
differentiated cells, and A2B5 and E-NCAM immunoreac-
tivity can be used to isolate purified fractions of restricted
precursor cells.
E-NCAM expression has been described on a variety of
cell types including mesodermal derivatives (Husmann et
al., 1989; Brunet et al., 1989; Gerety and Watanbe, 1997;
Dubois et al., 1994), epidermal derivatives (see for example
Muller-Rover et al., 1998), and astrocytes and oligodendro-
cytes (Seki and Arai, 1993; Bhat et al., 1988; Minana et al.,
1998). It was therefore somewhat surprising that a large
proportion of the E-NCAM-immunoreactive cells present
in differentiating ES cell cultures are neuroblasts. A pos-
sible explanation may lie in the fact that ES cell differen-
tiation was biased to neural versus epidermal or mesoder-
mal differentiation by aggregation and retinoic acid. Within
the developing neural tube E-NCAM immunoreactivity
appears limited to early developing neurons and their pre-
cursors at early stages of development (Mayer-Proschel et
al., 1997). Thus, the large proportion of E-NCAM-
immunoreactive cells that are neuroblasts may reflect not
just the specificity of the antibody, but also the specificity
of the culture conditions that we utilized to generate
neurons. Consistent with this possibility is our observation
that nonneuronal E-NCAM-immunoreactive cells are
present when ES cells are allowed to differentiate without
aggregation and the addition of retinoic acid (data not
shown). Under conditions in which neuronal E-NCAM
cells were present, our cultures also contained other neural
precursors such as A2B5-immunoreactive cells. A2B51 cells
appeared in a relatively higher proportion than E-NCAM-
immunoreactive cells (10 versus 5%). Thus, while signifi-
cant numbers of neurons and glial cells can be obtained, it
must be emphasized that the actual efficiency of the pro-
cess is rather low. Despite this low efficiency, however, we
would argue that ES cells represent the most likely source
of large numbers of cells for transplant tissue. ES cells can
be grown in culture indefinitely and indeed have been
grown in this fashion for years. Thus, it is possible to obtain
hundreds of millions of cells easily. Other laboratories have
shown that other classes of intermediate precursors can be
isolated from differentiating ES cells. For example, hema-
topoietic stem cells that are restricted to differentiation
into bone marrow stem cell derivatives have been isolated
from differentiating ES cells (reviewed in Weiss, 1997; see
also Suwabe et al., 1998). Similarly, a mesodermal stem cell
that can differentiate into cartilage, bone, and connective
tissue cells has been isolated from ES cell cultures (Katoka
et al., 1997). Our demonstration that two additional classes
of intermediate precursors (NRPs and GRPs) that can be
distinguished from the previously characterized precursors
extends the range of possible precursors, harvested from ES
cells, and suggests that ES cell cultures are a useful source
of dividing intermediate precursors that normally develop
at different stages in vivo.
Copyright © 1999 by Academic Press. All rightOur experimental design did not allow us to determine if
S cells first generate neuroepithelial cells that subse-
uently generate intermediate lineage restricted precursors
r that ES cells directly generate neuroblasts and glioblasts.
hese experiments are difficult to perform as no cell surface
arkers that will unambiguously distinguish NEP cells
rom ES and other cells exist. Thus, cell sorting and clonal
nalysis remain difficult to perform. Nevertheless recent
esults (Okabe et al., 1996; Li et al., 1998) suggest that
luripotent nestin-immunoreactive cells may also be gen-
rated from ES cell cultures under virtually identical cul-
ure conditions to those described in our present studies.
hus it is reasonable to assume that at least some neuro-
lasts or glioblasts arose from ES cells that went through a
EP-like stem cell phase. Direct demonstration of this
ransition would provide compelling evidence that in vitro
ifferentiation recapitulates in vivo development and allow
detailed analysis of neural differentiation that occurs over
3 days of embryonic development in a simple in vitro
odel.
In summary our results provide a culture model to study
he process of differentiation from totipotent ES cells to
ultipotent NEP stem cells to more restricted neuronal
nd glial precursors. Further, our results show that
-NCAM and A2B5 antibodies can be used for selectively
orting NRPs and GRPs and amplifying them through serial
assages for gene expression studies and therapeutic use.
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